Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. - Romond,E.H.; Perez,E.A.; Bryant,J.; Suman,V.J.; Geyer,C.E.; Davidson,N.E.; Tan-Chiu,E.; Martino,S.; Paik,S.; Kaufman,P.A.; Swain,S.M.; Pisansky,T.M.; et al. (N Engl J Med, 2005)